3.
Article 8(4) shall be replaced by the following: ‘4. The Commission shall adopt definitions of “similar medicinal product” and “clinical superiority” in the form of an implementing Regulation. Those measures, designed to amend non-essential elements of this Regulation by supplementing it, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 10a(3).’;
← anx_ANNEX__cpt_1__cpt_4__point_2__text_2 · All articles · anx_ANNEX__cpt_1__cpt_4__point_3__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-10-21 · Text as adopted (Official Journal); later amendments are not incorporated in this text.